Propel Bio Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Propel Bio Management LLC
CRD #322858
SEC #801-126889
CIK #0001969764
AUM 247.5 M (2026-03-23)
Employees 7 (86% Investors, 0% Brokers)
Fees
Minimum
Phone206-602-9246
Address11620 Wilshire Blvd
Los Angeles, CA 90025
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
2502001501005002010201520212027
Fees and Compensation — Form ADV Part 2A (3/23/2026) [Brochure]
Item 5 Fees and Compensation
The following sets forth a description of the advisory fee arrangements in effect with respect to the
Clients.

Private Fund
For its private fund Clients, Propel receives an asset-based management fee (the "Management Fee")
set forth in the private funds' governing documents.Propel or the General Partner, in its sole discretion,
may waive the Management Fee.

In addition, Propel receives performance-based compensation, which is compensation based on a
share of capital gains or capital appreciation of the assets of the private fund as is more fully set forth
in the governing documents of the private fund.

Propel will negotiate its compensation, if any, from co-investment opportunities on a case-by-case
basis, and such compensation may include asset-based fees, carried interest and expense
reimbursement or non-advisory administrative fees.

ETF
With respect to the ETF, Propel will receive a sub-advisory fee as set forth in the prospectus of the
ETF. The sub-advisory fee charged by Propel is documented in writing in an investment sub-advisory
agreement between the ETF's adviser, Simplify Asset Management, Inc. ("Simplify"), and the Simplify
Exchange Traded Funds Trust (the "Trust"). Such agreement has been approved by the Board of
Trustees of the Trust. Investors are encouraged to review the ETF's prospectus to understand its fees
and expenses, which includes expenses for custody, administration, and other non-advisory services.
Account Minimums and Types of Clients — Form ADV Part 2A (3/23/2026) [Brochure]
Item 7 Types of Clients
As described in Item 4, Propel's Clients are private funds and an ETF.

The private funds are private investment partnerships whose interests are offered to investors on a
private placement basis and is organized as a Delaware limited partnership. Capital commitments to
the private funds must be in a minimum amount of at least $1,000,000 for individuals and $5,000,000
for institutional investors, although the general partner of the private fund reserves the right to waive or
reduce this requirement in its sole discretion from time to time. An investment in the private fund is
limited to investors that are "accredited investors" within the meaning of Regulation D under the
Securities Act of 1933, as amended (the "Securities Act"). The private fund's governing documents
contain a complete discussion of the investor eligibility requirements and the terms and conditions of
an investment in the private fund.

The ETF is a U.S. investment company registered under the 1940 Act.
Sector Form 13F Holdings Value ($M)
Plains GP Holdings LP 30.2
Oncogenex Pharmaceuticals Inc 11.4
Phathom Pharmaceuticals Inc 9.4
Delcath Systems Inc 9.2
Corcept Therapeutics Inc 6.0
Access Pharmaceuticals Inc 6.0
Vor Biopharma Inc 5.6
Kyverna Therapeutics Inc 5.6
Milestone Pharmaceuticals Inc 5.1
Celldex Therapeutics Inc 4.1
View All
Holdings by Sector ($M)
180144108723602024202520262027
Type Form D Funds Date Sold AUM
HF Propel Bio-Host Partners LP 2025-12-02 99.3 M
Other Propel Bio SPV 3 LLC 2025-03-25 19.3 M
Other PB SPV-1 LLC 2024-07-09 2.5 M
Other Propel Bio SPV 2 LLC [2024-03-25] 8.8 M 9.2 M
Offered $8,800,000 · Filed 2024-03-12 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Net Assets Decline to Disclose
VC Propel Bio Partners LP [2022-10-17] 39.0 M 44.5 M
Offered $150,000,000 · Filed 2023-03-15 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $111,050,000 · Duration More than one year · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 1 75.3
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 172.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 5 247.5
By Discretionary
Discretionary 5 247.5
Non-Discretionary 0 0.0
Total 5 247.5
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 247.5
Total 5 247.5
Form D Directors Role # Filings # Firms 2011 - 2026
Leen Kawas Director 5 2
Propel Bio Management Director 2 2
A Delaware Limited Liability Company Pbp Partners LLC Director 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001969764]
SC 13D [0001969764]
SC 13G [0001969764]
Form 13D/13G Filer Form 13D/13G Subject Filed
Propel Bio Management LLC Milestone Pharmaceuticals Inc [2025-12-23]
Propel Bio Management LLC Achieve Life Sciences Inc [2024-05-17]
Propel Bio Management LLC Eiger Biopharmaceuticals Inc [2023-10-20]
Propel Bio Management LLC Eiger Biopharmaceuticals Inc [2023-08-15]
Propel Bio Management LLC Applied Therapeutics Inc [2023-05-02]
Firm Profile (Form ADV)
Discretionary AUM$0.0B
ServesInstitutional
Fund TypesHedge Fund
Comparable Firms State AUM
Coinshares Asset Management US LLC
NY 251.9 M
Karlov Street Capital LLC
FL 251.0 M
AC Investment Management LLC
NY 251.0 M
Farley Capital LP
250.3 M
Rivonia Road Capital LLC
CA 246.0 M
3B Capital Management LP
TX 245.9 M
Metronome Capital LLP
244.9 M
Kultura Capital Management LP
UT 244.7 M
Bandera Partners LLC
NY 244.1 M
ShoreVest Partners Ltd
244.0 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com